Public Employees Retirement System of Ohio trimmed its holdings in shares of CVS Health Co. ( - ) by 3.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 614,924 shares of the pharmacy operator's stock after selling 20,872 shares during the period. Public Employees Retirement System of Ohio's holdings in CVS Health were worth $27,604,000 at the end of the most recent quarter. Other large investors have also bought and sold shares of the company. Vega Investment Solutions bought a new stake in shares of CVS Health during the 4th quarter valued at $359,000. Vise Technologies Inc. grew its stake in shares of CVS Health by 23.4% during the fourth quarter. Vise Technologies Inc. now owns 11,703 shares of the pharmacy operator's stock worth $525,000 after purchasing an additional 2,219 shares during the period. DCM Advisors LLC grew its stake in shares of CVS Health by 15.5% during the fourth quarter. DCM Advisors LLC now owns 81,530 shares of the pharmacy operator's stock worth $3,435,000 after purchasing an additional 10,920 shares during the period. Orion Capital Management LLC bought a new stake in CVS Health in the fourth quarter valued at about $54,000. Finally, McIlrath & Eck LLC lifted its stake in CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after buying an additional 174 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds. CVS Health Stock Performance Shares of opened at $60.80 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The firm has a market cap of $76.91 billion, a price-to-earnings ratio of 16.61, a price-to-earnings-growth ratio of 0.98 and a beta of 0.60. CVS Health Co. has a one year low of $43.56 and a one year high of $72.51. The stock's 50-day moving average is $66.15 and its 200-day moving average is $59.41. CVS Health ( - ) last released its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The firm had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter in the prior year, the firm posted $1.31 EPS. The business's revenue was up 7.0% on a year-over-year basis. Equities analysts predict that CVS Health Co. will post 5.89 earnings per share for the current fiscal year. CVS Health Announces Dividend The firm also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 annualized dividend and a yield of 4.38%. CVS Health's payout ratio is currently 63.48%. Wall Street Analysts Forecast Growth Several research firms have recently issued reports on CVS. Cowen restated a \"buy\" rating on shares of CVS Health in a research report on Monday, May 5th. Robert W. Baird boosted their price objective on shares of CVS Health from $51.00 to $71.00 and gave the company a \"neutral\" rating in a report on Tuesday, April 15th. Truist Financial upped their target price on shares of CVS Health from $82.00 to $84.00 and gave the company a \"buy\" rating in a research note on Monday, May 12th. Wolfe Research lifted their price target on shares of CVS Health from 67.00 to 70.00 and gave the stock an \"overweight\" rating in a research report on Tuesday, February 11th. Finally, Leerink Partners upgraded shares of CVS Health from a \"market perform\" rating to an \"outperform\" rating and upped their price objective for the company from $55.00 to $75.00 in a research report on Thursday, February 13th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, CVS Health has a consensus rating of \"Moderate Buy\" and an average price target of $74.94. Insiders Place Their Bets In related news, SVP sold 7,513 shares of CVS Health stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now owns 8,394 shares of the company's stock, valued at approximately $556,941.90. The trade was a 47.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through . Insiders own 1.22% of the company's stock. CVS Health Profile () CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Public Employees Retirement System of Ohio Sells 20,872 Shares of CVS Health Co. (NYSE:CVS)

The Public Employees Retirement System of Ohio reduced its holdings in CVS Health by 3.3% in Q4, selling 20,872 shares. Other investors, including Vega Investment Solutions, Vise Technologies Inc., and DCM Advisors LLC, adjusted their stakes. CVS Health reported $2.25 EPS, a 63.48% payout ratio, and a $76.91B market cap. Analysts raised price targets, and insiders, including an SVP, sold shares. The company also declared a $0.665 dividend.